Assenagon Asset Management S.A.
Position in ORGO — Organogenesis Holdings Inc.
CIK 1546007
SENNINGERBERG, N4
Position in ORGO
as of Jun 30, 2026
· filed Aug 21, 2026
Position Value
$4,782,123
+$118,077 QoQ
Shares Held
1,967,952
0.0% QoQ
Ownership
1.53%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#8
of 135 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ORGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Assenagon Asset Management S.A. holds $514,912,865 across 20 Drug Manufacturers - Specialty & Generic names. ORGO ranks #11 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,056,017 | $103,537,855 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
714,980 | $79,319,881 | |
| 3 | VTRS |
Viatris Inc
|
4,989,006 | $79,225,415 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
1,540,928 | $63,224,275 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
84,538 | $45,805,224 | |
| 6 | AMRX |
Amneal Pharmaceuticals, Inc.
|
2,445,549 | $42,332,453 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
222,606 | $37,518,015 | |
| 8 | ZTS |
Zoetis Inc.
|
389,335 | $27,977,613 |
All Filings in ORGO
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,782,123 | 1,967,952 | Shares | Sole | 2026-08-21 | |
| 2026-03-31 | $4,664,046 | 1,967,952 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $28,673,030 | 5,535,334 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $20,487,855 | 4,854,942 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $10,459,928 | 2,857,904 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $1,455,680 | 336,963 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $9,442,716 | 2,950,849 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $5,478,984 | 1,915,729 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $11,135,947 | 3,977,124 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $2,759,554 | 971,674 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $3,974,146 | 971,674 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $3,089,923 | 971,674 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $4,532,454 | 1,365,197 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $2,907,869 | 1,365,197 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $3,873,707 | 1,440,040 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $6,513,848 | 2,010,447 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $9,776,235 | 2,003,327 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $12,577,892 | 1,650,642 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $11,737,137 | 1,270,253 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $16,094,076 | 1,130,202 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $15,025,560 | 904,065 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $16,447,285 | 902,705 | Shares | Sole | 2021-04-26 | |
| No filing history on record for this holder in this stock. | ||||||